510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2350-2015Class II

PathoDx Strep Grouping Kit, REF 62025, packaged 60 tests per kit. Latex agglutination test for identification...

Remel Inc / initiated 2015-06-30 / Terminated

Remel Inc began a recall of PathoDx Strep Grouping Kit, REF 62025, packaged 60 tests per kit. Latex agglutination test for identification of beta-hemolytic streptococci of Lancefield... on . FDA classified it as Class II and gives the reason as "A reagent present may produce weak or slow reactions; continued use may result in a failure to identify target species". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-2350-2015
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Remel Inc
Product
PathoDx Strep Grouping Kit, REF 62025, packaged 60 tests per kit. Latex agglutination test for identification of beta-hemolytic streptococci of Lancefield Groups A, B, C, F or G from primary culture plates.
Product code
GTY Antigens, All Groups, Streptococcus Spp.
Reason for recall
A reagent present may produce weak or slow reactions; continued use may result in a failure to identify target species.
FDA root cause
Under Investigation by firm
Action
On 4/28/2015, the recalling firm's European subsidiary notified the recalling firm of the recall. On 6/30/2015, the recalling firm notified their customers of the recall via letter, sent USPS standard mail.
Quantity in commerce
1859 kits
Distribution
Nationwide Distribution, including Puerto Rico and the country of Canada.
Product codes and lots
lot 1470133, exp. date 31 Mar 2016

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2350-2015
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2350-2015Class IITerminatedVoluntary: Firm initiated
Z-2351-2015Class IITerminatedVoluntary: Firm initiated